share_log

Jim Cramer Says This Energy Stock Is 'Terrific,' Calls Casey's General Stores A 'Winner'

Benzinga ·  Apr 24 08:15

On CNBC's "Mad Money Lightning Round," Jim Cramer recommended selling Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR). "I like PBR the beer more than I like PBR the oil company," he added.

Cramer recommended buying Enterprise Products Partners L.P. (NYSE:EPD).

On April 4, Wells Fargo analyst Michael Blum maintains Enterprise Products Partners with an Overweight rating and raised the price target from $32 to $33, while Scotiabank analyst Tristan Richardson maintained the stock with a Sector Outperform and boosted the price target from $31 to $32.

Cheniere Energy, Inc. (NYSE:LNG) is "terrific," Cramer said.

The "Mad Money" host recommended buying Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX). "I think you have a real winner," he noted.

On April 16, Recursion named Najat Khan, PhD, as chief R&D officer and chief commercial officer.

Cramer said Casey's General Stores, Inc. (NASDAQ:CASY) is a "winner" and recommended buying the stock.

On April 16, Evercore ISI Group analyst Michael Montani maintained Casey's General with an Outperform and lowered the price target from $350 to $345.

Broadcom Inc. (NASDAQ:AVGO) is a buy, Cramer said.

On Monday, critics of Broadcom dismissed the U.S. chipmaker's revisions to its cloud licensing practices, arguing that the changes fail to resolve their concerns over alleged price increases, unfair software licensing terms, and product bundling.

Price Action:

  • Petroleo Brasileiro shares rose 0.1% to settle at $16.96 on Tuesday.
  • Broadcom shares gained 2% to settle at $1,249.19.
  • Casey's General Stores shares fell 0.1% to close at $313.32 on Tuesday.
  • Enterprise Products Partners shares fell 0.3% to close at $28.91.
  • Recursion Pharmaceuticals shares rose 1.3% to settle at $7.70 on Tuesday.
  • Cheniere Energy shares fell 1% to close at $158.90 on Tuesday.

Photo: Shutterstock

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment